weight regain after stopping glp-1 agonists cessation of medication for weight management: systematic review and meta-analysis Weight gain after stopping :

Left unchecked, it can cause fatty deposits to build up in artery walls, raising the risk of heart attack, stroke and other cardiovascular disease

Diabetes Care 40 , 10731081 (2017)

Newer injectables can cost thousands without insurance coverage

Employing preclinical, ex vivo, in vivo, and in vitro model systems investigators determined that GLP-1 agonists exert anti-inflammatory and immune modulating effects through their effects on macrophages (reduced interleukin [IL] 1, IL-6, tumor necrosis factor [TNF], and C-X-C motif chemokine ligand [CXCL]), T and B lymphocytes (reduced cluster of differentiation [CD] 4 cells), monocytes (increased IL-10), mononuclear cells (decreased monocyte chemoattractant protein [MCP]1, cell death protein [PD],, CD4 and CD8 T cells) [5155]

Ethics declarations Conflicts of Interest T